Leerink Upgrades Replimune to Outperform, Sees High Odds of FDA Approval for Melanoma Therapy
Leerink upgrades Replimune to Outperform with $17 target, citing high odds of FDA accelerated approval for RP-1 melanoma therapy after 10-3 vote.
NOTRELOAD AI
Hut 8 Misses Q2 Estimates but Locks In $26.6 Billion in AI Data Center Contracts
Hut 8 Corp. missed Q2 estimates but secured 949 MW of AI capacity, $26.6B in contracts, $7.5B financing, and fully commercialized its Beacon Point campus.
SHAZ Signs $373m AI Cloud Agreement, Contracts 120MW of Capacity
Sharon AI signs a US$373 million five-year AI cloud agreement with a global platform, contracting 120MW capacity and 2,048 NVIDIA Blackwell GPUs.
Caterpillar Shares Jump as Strong Demand Drives Record Sales and Higher Guidance
Caterpillar reports record $20.5B Q2 sales (+24%), $8.17 adjusted EPS, and raises full-year growth forecast amid strong AI and construction demand.
McDonald’s Q2 Earnings: Profit Tops Forecasts but U.S. Sales Miss
McDonald’s U.S. same-store sales rose just 0.8% in Q2, missing forecasts despite value menus and deals aimed at lower-income customers.
BofA Downgrades Duolingo to Underperform, Cuts Price Target to $93
BofA cuts Duolingo’s rating, warning that high valuation, AI risks, and uncertain growth could pressure the stock.